跳至主要内容
临床试验/ISRCTN61378987
ISRCTN61378987已完成不适用

Measles, mumps and rubella vaccine given to 14 month old children, administered subcutaneously versus intramuscularly

ational Institute of Public Health and Environmental Protection (RIVM) (The Netherlands)0 个研究点目标入组 67 人开始时间: 2007年5月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
67

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children aged 12 to 18 months
  • 2. In good general health

排除标准

  • 1. Proven allergy for any of the vaccine components
  • 2. Contraindication for MMR vaccination (e.g. administration of blood products within three months before MMR vaccination)
  • 3. Known immune disorder
  • 4. Coagulation disorder (not being able to receive intramuscular injection)
  • 5. Parents/legal representatives who cannot participate optimally in the trial due to, e.g., language issues
  • 6. Previous MMR vaccination
  • 7. Administration of another vaccine simultaneous to the MMR vaccination

研究者

发起方
ational Institute of Public Health and Environmental Protection (RIVM) (The Netherlands)

相似试验